Banner for leaf pages 2


Also known as Nexavar

Sorafenib (co-developed and co-marketed by Bayer and Onyx Pharmaceuticals as Nexavar), is a drug approved for the treatment of primary kidney cancer (advanced renal cell carcinoma) and advanced primary liver cancer (hepatocellular carcinoma).

Source: Wikipedia

Estimated Total Cost: $5379.67 for an average of 28 days supply

What is it prescribed for?

Patients are most commonly prescribed sorafenib to treat liver cancer, metastatic cancer, anemia, and viral hepatitis.

What drug interactions are known?

Do not take sorafenib if you are taking any of the following:

Critical Interactions

Significant Interactions

Ajax-loader Loading...